SciSparc Ltd. (SPRC) Stock
Healthcare · Biotechnology · Member of Other US Stocks
SciSparc Ltd. (SPRC) closed at USD 3.63 on 2026-10-14, a change of -89 % over the past year, with a market capitalization of USD 46.15M.
SciSparc Ltd. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 3.63 |
| 2026-10-13 | 3.94 |
| 2026-10-12 | 4.08 |
| 2026-10-09 | 4.47 |
| 2026-10-08 | 4.43 |
| 2026-10-07 | 4.64 |
| 2026-10-06 | 4.33 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
SciSparc Ltd. key figures
- Previous close
- USD 3.63 (2026-10-14)
- 1-year change
- -89 %
- Market cap
- USD 46.15M
- Enterprise value
- USD 6.73M
- P/E ratio (trailing)
- 0.02
- P/E ratio (forward)
- n/a
- EPS (trailing)
- 126.01
- EPS (forward)
- n/a
- PEG ratio
- n/a
- Price to book
- 0.29
- Revenue growth
- -38.4 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.39
- Employees
- 3
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About SciSparc Ltd.
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for SciSparc Ltd. and compare it with other stocks.
Analyze SPRCAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell SciSparc Ltd. shares.